36C25020Q0540-001.pdf

This notice is for a sole source contract opportunity for the acquisition of Zeiss OS CIRRUS HD-OCT systems with AngioPlex OCT Angiography software upgrades and new units. The Louis Stokes Cleveland VA Medical Center requires the equipment to enhance retinal diagnostic capabilities for their high volume of complicated retina cases. The upgrades are needed for six existing Zeiss CIRRUS HD-OCT units and three new units are required. The AngioPlex OCT angiography technology provides improved detection of new blood vessel growth associated with vision loss conditions like diabetes and macular degeneration. A determination on competing the proposed sole source award to Corps Biologics LLC, the authorized SDVOSB distributor for Zeiss, is within the discretion of the agency by April 24, 2019. The sole source justification is based on the proprietary nature of the AngioPlex software and hardware integration requirements for the upgrades and existing Zeiss FORUM image database platform.